John Sakys Sells 2,827 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) CFO John Sakys sold 2,827 shares of Mesa Laboratories stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $89.50, for a total transaction of $253,016.50. Following the sale, the chief financial officer owned 19,785 shares of the company’s stock, valued at approximately $1,770,757.50. This represents a 12.50% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

John Sakys also recently made the following trade(s):

• On Tuesday, June 16th, John Sakys sold 1,223 shares of Mesa Laboratories stock. The shares were sold at an average price of $101.27, for a total transaction of $123,853.21.

Mesa Laboratories Price Performance

Shares of MLAB stock opened at $94.45 on Thursday. The firm’s 50 day moving average price is $101.80 and its two-hundred day moving average price is $91.21. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.29 and a current ratio of 1.72. Mesa Laboratories, Inc. has a 52-week low of $55.45 and a 52-week high of $113.99. The stock has a market cap of $521.36 million, a PE ratio of 78.71 and a beta of 0.94.

Mesa Laboratories (NASDAQ:MLAB) last issued its earnings results on Wednesday, May 27th. The medical instruments supplier reported $1.53 EPS for the quarter, missing the consensus estimate of $1.78 by ($0.25). The business had revenue of $63.72 million for the quarter, compared to the consensus estimate of $65.21 million. Mesa Laboratories had a net margin of 2.69% and a return on equity of 20.96%. During the same quarter in the previous year, the firm posted ($1.31) EPS.

Mesa Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Friday, May 29th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Friday, May 29th. Mesa Laboratories’s dividend payout ratio is currently 53.33%.

Analyst Ratings Changes

Separately, Weiss Ratings cut Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, June 3rd. Two analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus target price of $94.00.

Hedge Funds Weigh In On Mesa Laboratories

A number of hedge funds and other institutional investors have recently made changes to their positions in MLAB. Mason Capital Management LLC acquired a new stake in Mesa Laboratories during the 3rd quarter worth $4,711,000. Crawford Investment Counsel Inc. grew its stake in Mesa Laboratories by 59.4% in the third quarter. Crawford Investment Counsel Inc. now owns 82,467 shares of the medical instruments supplier’s stock valued at $5,526,000 after acquiring an additional 30,723 shares during the period. Roubaix Capital LLC acquired a new position in Mesa Laboratories in the third quarter valued at about $5,137,000. Gabelli Funds LLC increased its holdings in shares of Mesa Laboratories by 114.6% in the third quarter. Gabelli Funds LLC now owns 53,974 shares of the medical instruments supplier’s stock worth $3,617,000 after acquiring an additional 28,818 shares in the last quarter. Finally, Diamond Hill Capital Management Inc. increased its holdings in shares of Mesa Laboratories by 15.1% in the fourth quarter. Diamond Hill Capital Management Inc. now owns 141,973 shares of the medical instruments supplier’s stock worth $11,145,000 after acquiring an additional 18,592 shares in the last quarter. 90.60% of the stock is owned by institutional investors.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.